002737 葵花药业
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.049-6.27510.76424.95821.916
总资产报酬率 ROA (%)1.495-4.6237.74416.08713.693
投入资产回报率 ROIC (%)1.843-5.76610.07021.73718.557

边际利润分析
销售毛利率 (%)54.91938.15244.89356.29157.749
营业利润率 (%)6.734-10.83718.84023.97821.297
息税前利润/营业总收入 (%)6.630-11.87018.10423.20621.002
净利润/营业总收入 (%)5.706-12.81614.88720.43617.857

收益指标分析
经营活动净收益/利润总额(%)119.48996.78580.63488.88396.075
价值变动净收益/利润总额(%)2.796-12.8861.8832.257-0.917
营业外收支净额/利润总额(%)-1.0257.363-0.277-0.890-0.359

偿债能力分析
流动比率 (X)3.4723.0413.7823.1502.235
速动比率 (X)2.8542.5052.9372.5761.944
资产负债率 (%)23.16025.10421.21427.27836.876
带息债务/全部投入资本 (%)6.0835.6431.924-0.50811.146
股东权益/带息债务 (%)1,477.3291,594.6834,866.788-18,419.112725.122
股东权益/负债合计 (%)318.884286.944354.335253.749162.156
利息保障倍数 (X)-187.88168.996-26.468-41.386-95.903

营运能力分析
应收账款周转天数 (天)6.55120.95814.6096.89412.250
存货周转天数 (天)166.477186.420168.347108.747112.202